1. DOP056 Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn's disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study. (16th January 2018) Authors: Matsuoka, K; Naganuma, M; Tanida, S; Kitamura, K; Matsui, T; Arai, M; Fujiya, M; Horiki, N; Nebiki, H; Kinjo, F; Miyazaki, T; Matsumoto, T; Esaki, M; Mitsuyama, K; Saruta, M; Ido, A; Hojo, S; Takenaka, O; Oketani, K; Imai, T Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term outcomes evaluated by device-monitored physical activity in patients with implantable cardiac defibrillator or cardiac resynchronization therapy device. (25th November 2020) Authors: Yokomatsu, T; Kato, M; Hojo, S; Kawaji, T; Kushiyama, A; Yaku, H; Nakatsuma, K; Kaneda, K; Miki, S Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0187 Safety, pharmacokinetics and efficacy of e6011, an anti-fractalkine monoclonal antibody, in a first-in-patient phase 1/2 study in rheumatoid arthritis; addtional data of 400 mg cohort. (15th June 2017) Authors: Tanaka, Y; Takeuchi, T; Umehara, H; Nanki, T; Yasuda, N; Tago, F; Kitahara, Y; Kawakubo, M; Hojo, S; Kawano, T; Imai, T Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗